France 2030 Launches Major Initiative to Integrate Mature Healthcare Innovations Through Strategic Public Procurement
The French government has officially launched a new Call for Projects (AAP) titled "Innovative Public Purchasing within Healthcare Facilities," a strategic move designed to accelerate the adoption of mature technological and organizational solutions within the national health system. Initiated on April 10, 2024, this program represents a collaborative effort between the Health Innovation Agency (AIS), the National Agency for Health and Medico-Social Performance (ANAP), and the General Directorate of Care Provision (DGOS). Operating under the ambitious "France 2030" investment plan, the initiative seeks to leverage public procurement as a primary engine for modernization, ensuring that cutting-edge medical and administrative tools move beyond the pilot phase and into large-scale clinical and operational use.
A Strategic Shift in Healthcare Modernization
For years, the French healthcare ecosystem has been recognized for its vibrant startup culture and high-quality research. However, many innovative companies have faced a "valley of death" when attempting to transition from successful prototypes to widespread adoption within public and private hospitals. The complexity of public procurement rules, combined with budget constraints and a cautious approach to organizational change, has often slowed the integration of solutions that could otherwise improve patient outcomes and facility efficiency.
The newly launched AAP addresses these bottlenecks directly. By providing financial support and a structured framework for purchasing, the State aims to de-risk the acquisition of innovation for healthcare facilities. The focus is explicitly on "mature" innovations—solutions that are already technically sound, commercially available, and ready for immediate deployment. This shift marks a departure from funding research and development toward funding the actual implementation and scaling of proven technologies.
Stéphanie Rist, the Minister of Health, Families, Autonomy, and Persons with Disabilities, emphasized that this initiative is central to her vision for the future of the French medical landscape. According to the Minister, innovation must no longer be viewed as an experimental luxury but as a fundamental "vector of transformation" for professional practices. By mobilizing the France 2030 framework, the government is not only seeking to modernize hospitals but also to provide a domestic market for French and European health-tech companies, allowing them to demonstrate their value at home before expanding globally.
The Role of France 2030 and Inter-Agency Collaboration
The France 2030 plan, a €54 billion investment strategy launched by President Emmanuel Macron, serves as the financial and structural backbone of this project. Within this plan, the "Health 2030" pillar is dedicated to making France a leader in healthcare innovation. The AAP "Innovative Public Purchasing" is a key component of this broader ambition, focusing on the downstream end of the innovation cycle.
The involvement of three distinct agencies ensures a holistic approach to the project’s execution:
- The Health Innovation Agency (AIS): Responsible for the overall coordination of the Health 2030 strategy, the AIS ensures that the selected projects align with national health priorities and long-term industrial goals.
- The National Agency for Health and Medico-Social Performance (ANAP): ANAP provides the technical expertise required to evaluate the performance of these innovations. They are tasked with selecting the projects and monitoring their impact on the ground, ensuring that the investments lead to tangible improvements in facility management and care delivery.
- The General Directorate of Care Provision (DGOS): As the body responsible for the regulation and organization of the healthcare offering in France, the DGOS ensures that the innovations integrated through this AAP are compatible with existing healthcare structures and regulatory requirements.
Bruno Bonnell, the Secretary General for Investment in charge of France 2030, noted that public procurement is being reimagined as a "strategic function." Rather than a mere administrative hurdle, it is being utilized as a lever to boost the performance of healthcare establishments and the economic growth of innovative enterprises.
Priority Domains for Innovation
To ensure the funding has the greatest possible impact, the government has identified five priority areas where innovation is most urgently needed. These domains reflect the current pressures facing the French healthcare system, including an aging population, professional burnout, and the need for environmental sustainability.
1. Organizational Innovation in Support Functions and HR
The healthcare sector is currently grappling with significant recruitment and retention challenges. Innovations in this category focus on optimizing human resources management, automating administrative tasks, and improving the daily logistical operations of hospitals. By reducing the administrative burden on medical staff, these tools allow healthcare professionals to focus more on direct patient care.
2. Patient Pathways and Coordination
Improving the fluidity of care as patients move between home, primary care, and hospital settings is a major goal. This includes digital platforms for remote monitoring, integrated care coordination tools, and solutions that facilitate the "virage ambulatoire" (the shift toward outpatient care).
3. The Operating Room
As the most resource-intensive area of any hospital, the operating room is a prime target for efficiency gains. This includes advanced surgical assistance, real-time data analytics for theater management, and innovations that reduce recovery times or minimize surgical risks.
4. Diagnostics and Clinical Practice
This domain covers mature AI-driven diagnostic tools, point-of-care testing, and advanced imaging technologies. The goal is to provide faster, more accurate diagnoses, which lead to earlier interventions and better long-term outcomes.
5. Ecological Transition
In line with national climate goals, the healthcare sector must reduce its carbon footprint. This priority area seeks innovations in waste management, energy efficiency for large medical campuses, and the reduction of single-use plastics in clinical settings.
Eligibility, Funding, and Timeline
The AAP is open to a wide range of participants, reflecting the collaborative nature of modern healthcare. Eligible applicants include public or private healthcare and medico-social establishments, either individually or as part of a consortium. They must partner with the providers of the innovative solutions—typically startups or Small and Medium Enterprises (SMEs) that hold the rights to or distribute the technology.
Each project must have a minimum budget of €150,000, ensuring that the initiatives are of a sufficient scale to produce meaningful data. The duration of the projects is expected to be between 12 and 24 months. This timeframe is designed to allow for a robust implementation phase followed by a period of evaluation.
The selection process is rigorous. Projects will be judged on several criteria:
- Technical Maturity: The solution must be ready for market and immediate use.
- Replicability: There must be a clear potential for the solution to be scaled nationally if the initial deployment is successful.
- Measurable Impact: Applicants must demonstrate how they will measure improvements in care quality, working conditions, or environmental sustainability.
The program is structured in three successive waves over a three-year period, allowing for continuous learning and adjustment. The first wave of applications is currently open, with a final deadline of June 30, 2026. This multi-year approach provides healthcare facilities with the time needed to identify partners and draft comprehensive transformation plans.
Evaluation and the Path to National Scaling
A unique aspect of this Call for Projects is the emphasis on "evidence-based" innovation. ANAP will lead the evaluation process, conducting both "ante" (before) and "post" (after) deployment assessments. This rigorous monitoring is intended to produce tangible proof of efficiency in real-world conditions.
Stéphane Pardoux, Director General of ANAP, highlighted that the agency’s expertise will be used to identify "generalisable levers." The data collected from these projects will not stay within the walls of a single hospital; instead, it will be used to create blueprints for national implementation. If a specific AI diagnostic tool is proven to reduce costs and improve accuracy in a group of hospitals in Lyon, the evidence generated through this AAP will be used to facilitate its adoption in Paris, Marseille, and beyond.
Broader Implications for the French Healthcare System
The "Innovative Public Purchasing" initiative arrives at a critical juncture. The French healthcare system, like many others in Europe, is facing a "scissors effect": increasing demand for care due to an aging population and chronic diseases, coupled with a shrinking workforce and tightening budgets.
By investing millions of euros into the deployment of mature innovations, the State is betting that technology can help resolve this tension. The focus on "working conditions" is particularly significant. By adopting tools that automate mundane tasks or improve scheduling, hospitals can address the root causes of caregiver burnout, which is essential for the long-term sustainability of the system.
Furthermore, this initiative strengthens France’s "sovereignty" in health. By supporting domestic startups through public procurement, the government is ensuring that the country remains at the forefront of medical technology. This reduces reliance on non-European providers and fosters a robust industrial base that can export its solutions globally.
In conclusion, the launch of this AAP represents a maturing of the France 2030 strategy. It moves from the theoretical promise of innovation to the practical reality of hospital management. By bridging the gap between innovative companies and healthcare providers through the strategic use of the public purse, France aims to create a more efficient, resilient, and technologically advanced healthcare system for the mid-21st century. Success will be measured not just by the number of projects funded, but by the lasting improvements in the quality of life for both patients and the professionals who care for them.
Related posts:
